Artificial Intelligence Advances Early Detection of Blood Mutations Linked to Cancer and Heart Disease
A new AI-powered tool from Mayo Clinic improves early detection of blood mutations linked to increased risks of cancer and heart disease, potentially enabling proactive patient care.
Researchers at Mayo Clinic have developed an innovative artificial intelligence (AI) tool capable of identifying early blood mutations associated with an increased risk of cancer, particularly leukemia, and cardiovascular diseases. These blood mutations, often present in a slow-growing cluster of mutated blood cells, occur in approximately 20% of older adults and can significantly elevate disease risk without obvious symptoms.
This condition, known as clonal hematopoiesis of indeterminate potential (CHIP), originates in the bone marrow where blood stem cells normally produce cells vital for oxygen transport, immune defense, and organ function. When these stem cells acquire mutations in genes linked to blood cancers, they can multiply abnormally, forming clusters of mutated cells that expand over time. Although CHIP is usually asymptomatic, it has been linked to a higher incidence of death, notably from heart disease, and increases the likelihood of developing leukemia more than tenfold.
To better understand and detect this hidden risk, Mayo Clinic researchers created UNISOM (Unified Somatic Calling and Machine Learning), an advanced tool that pinpoints CHIP-related mutations within standard genetic datasets. Developed under the leadership of Ph.D. scholars Shulan Tian and Eric Klee, UNISOM enables clinicians to identify mutations that traditional methods often miss, especially those present in fewer than 5% of blood cells, by analyzing whole-exome and whole-genome sequencing data.
Detecting these early genetic changes enhances the potential for proactive monitoring and personalized disease prevention strategies. Dr. Klee emphasizes that early molecular detection signifies a major step forward in personalized medicine, translating genomic discoveries into practical clinical tools. Dr. Tian highlights that the tool has already demonstrated high accuracy, identifying nearly 80% of CHIP mutations, and aims to be expanded to larger, more diverse datasets to support wider clinical use.
Understanding and identifying CHIP mutations early may lead to improved management of patients at risk, ultimately reducing the burden of blood cancers and cardiovascular diseases among aging populations.
Source: https://medicalxpress.com/news/2025-08-ai-tool-early-blood-mutations.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Indigenous Women's Perspectives on Birth Care and Preferred Alternatives Globally
Indigenous women worldwide face barriers in maternity care due to cultural insensitivity and discrimination. This article explores their experiences and highlights alternative models like birthing on Country to ensure respectful, culturally safe childbirth care.
Significant Share of Colonoscopy Bowel Preparation Claims Involve Patient Cost-Sharing
A study reveals that a substantial percentage of patients undergoing colonoscopy prep face out-of-pocket costs, emphasizing the need for better coverage enforcement to improve access and promote preventive care.
Artificial Intelligence Gap Impeding Healthcare Advancements in the Global South
A new study highlights the global disparities in AI adoption in healthcare, emphasizing the challenges faced by the Global South and the need for equitable international collaboration to foster health equity.
Could Caffeine Play a Role in Preventing Sudden Infant Death Syndrome?
Research suggests caffeine might help prevent Sudden Infant Death Syndrome by counteracting low oxygen episodes in infants. This innovative hypothesis could open new pathways for prevention strategies in infant health.